170 related articles for article (PubMed ID: 24395789)
1. Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.
Hatcher RJ; Dong J; Liu S; Bian G; Contreras A; Wang T; Hilsenbeck SG; Li Y; Zhang P
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1008-13. PubMed ID: 24395789
[TBL] [Abstract][Full Text] [Related]
2. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
4. mTOR promotes pituitary tumor development through activation of PTTG1.
Chen R; Duan J; Li L; Ma Q; Sun Q; Ma J; Li C; Zhou X; Chen H; Jing Y; Zhao S; Wu X; Zhang H
Oncogene; 2017 Feb; 36(7):979-988. PubMed ID: 27524416
[TBL] [Abstract][Full Text] [Related]
5. PTTG1 attenuates drug-induced cellular senescence.
Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
[TBL] [Abstract][Full Text] [Related]
6. Loss of cyclin D1 in concert with deregulated estrogen receptor alpha expression induces DNA damage response activation and interrupts mammary gland morphogenesis.
Frech MS; Torre KM; Robinson GW; Furth PA
Oncogene; 2008 May; 27(22):3186-93. PubMed ID: 18071314
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.
Hamid T; Malik MT; Kakar SS
Mol Cancer; 2005 Jan; 4(1):3. PubMed ID: 15649325
[TBL] [Abstract][Full Text] [Related]
8. [The Influence of the Minor Short Isoform of Securin (PTTG1) on Transcription is Significantly Different from the Impact of the Full Isoform].
Demin DE; Uvarova AN; Klepikova AV; Schwartz AM
Mol Biol (Mosk); 2020; 54(1):51-59. PubMed ID: 32163388
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
Meng C; Zou Y; Hong W; Bao C; Jia X
Mol Med; 2020 Apr; 26(1):33. PubMed ID: 32272902
[TBL] [Abstract][Full Text] [Related]
10. Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth.
Zhang G; Zhao Q; Yu S; Lin R; Yi X
Tumour Biol; 2015 Jan; 36(1):199-203. PubMed ID: 25227666
[TBL] [Abstract][Full Text] [Related]
11. Pttg1 Promotes Growth of Breast Cancer through P27 Nuclear Exclusion.
Xiea Y; Wangb R
Cell Physiol Biochem; 2016; 38(1):393-400. PubMed ID: 26824458
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
[TBL] [Abstract][Full Text] [Related]
13. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
14. PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis.
Méndez-Vidal C; Gámez-Del Estal MM; Moreno-Mateos MA; Espina-Zambrano AG; Torres B; Pintor-Toro JA
Cell Death Dis; 2013 Mar; 4(3):e530. PubMed ID: 23470537
[TBL] [Abstract][Full Text] [Related]
15. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Liang M; Chen X; Liu W; Li S; Li C; Jiang L; Lv S
Cancer Biol Ther; 2011 Feb; 11(3):337-45. PubMed ID: 21099350
[TBL] [Abstract][Full Text] [Related]
16. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein.
Chen PY; Tien HJ; Chen SF; Horng CT; Tang HL; Jung HL; Wu MJ; Yen JH
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649138
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
[TBL] [Abstract][Full Text] [Related]
18. Critical differences between isoforms of securin reveal mechanisms of separase regulation.
Han X; Poon RY
Mol Cell Biol; 2013 Sep; 33(17):3400-15. PubMed ID: 23798554
[TBL] [Abstract][Full Text] [Related]
19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis.
Vlotides G; Eigler T; Melmed S
Endocr Rev; 2007 Apr; 28(2):165-86. PubMed ID: 17325339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
